Wednesday 11th October 2023
New hope for Raynaud’s treatments after researchers confirm genetic causes
Researchers have, for the first time, identified two genes that can increase the risk of developing Raynaud’s.
Tuesday 3rd October 2023
The British Society for Rheumatology Annual Conference 2023: Research Round-Up
Earlier in the year we attended the British Society for Rheumatology Annual Conference, joining over 2,300 attendees which included leading doctors, nurses, and healthcare professionals working in the field. The conference was a fantastic opportunity to raise awareness of Scleroderma and Raynaud’s, and we got the chance to hear about some of the latest research aiming to improve our understanding of the conditions and open new avenues of care. Read on to learn more about some of the exciting projects we heard about at the conference!
Monday 10th October 2022
Winter Vaccinations: Get Your COVID-19 Boosters & Flu Vaccines Now!
To help protect those at risk from COVID-19 & flu, the NHS is currently offering flu vaccines and an autumn COVID booster to those with weakened immune systems, the over 50s, and household members of those who are deemed clinically vulnerable. These vaccines can reduce your chances of catching the viruses and getting seriously ill as a result of them. It's as important as ever to make sure that you, and those in close contact to you, are protected from infection before winter rolls around, so read more about how to get both vaccines here!
Wednesday 5th October 2022
Reducing Uncertainty in the Progression of Lung Fibrosis in Scleroderma Patients
Having scleroderma often means living with uncertainty around how the disease will progress over time, and the effect that this could have on future quality of life. New research funded by SRUK aims to help address the impact of this ‘prognostic uncertainty’, by using indicators that will predict disease progression and ultimately improve treatment options.
Thursday 21st October 2021
2021 Flu Season - Are you at risk? Are you eligible for the vaccine?
With autumn now firmly upon us, we are facing the onset of the winter flu season. If you have systemic sclerosis you may be at a higher risk if you catch the flu. What can you do to protect yourself?
Tuesday 19th October 2021
UPDATED: Breaking News - NICE approve Nintedanib for use in PF-ILD, which includes SSc Interstitial Lung Disease
SRUK are pleased to announce that NICE have approved the use of Nintedanib in treating progressive fibrosing interstitial lung disease (PF-ILD)!
Friday 15th October 2021
Stratified Medicine - The Latest SRUK Grant Call
What is stratified medicine? Stratified medicine is also known as personalised medicine and works by dividing patients within the larger group into subgroups by factors that make their condition different.
Friday 1st October 2021
Creating Clinical Trials for Children
: Affecting around 200 children in the UK, Juvenile Localised Scleroderma is an incredibly rare condition. Developing new treatments is challenging due to small numbers of patients. Find out how SRUK and Alder Hey are tackling this!
Wednesday 21st October 2020
Warp speed to a COVID-19 vaccine? The race is on!
In the fight against coronavirus, an effective vaccination could be the game-changer that the world is waiting for. It typically takes several years to develop a new vaccine, so how close are we to finding a real vaccination for coronavirus, and how might this work to protect us?
Friday 9th October 2020
Have you given your risk of flu a second thought?
Many people are entitled to a free flu jab this year, and you may have received a letter about this. But why is this important and what are the benefits? And is there anyone who should not have the flu vaccine? We have all the answers you need.